We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Theracryf Plc | LSE:TCF | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.775 | 0.75 | 0.80 | 0.775 | 0.775 | 0.775 | 197,320 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 396k | -3.14M | -0.0073 | -1.10 | 3.31M |
From Jul 2019 to Jul 2024
TIDMTCF
RNS Number : 4875E
Terra Catalyst Fund
08 May 2017
8(th) May 2017
TERRA CATALYST FUND
Net Asset Value of the Company
The Directors of Terra Catalyst Fund ("the Company") wish to announce that the final Net Asset Value for the Company as of 28(th) April 2017 was 236.40 pence per share.
-ends-
This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.
ENQUIRIES TO:
Quintillion Ltd
Eoghan McAteer
Tel: +353 1 523 8022
Smith & Williamson Corporate Finance Limited
Azhic Basirov
Tel: +44 (0)20 7131 4000
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVFMGGKZRRGNZM
(END) Dow Jones Newswires
May 08, 2017 09:30 ET (13:30 GMT)
1 Year Theracryf Chart |
1 Month Theracryf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
